HSPA4

HSPA4 is an HSP110-family nucleotide exchange factor for HSP70 chaperones that supports protein quality control across multiple tissues, with loss-of-function phenotypes converging on accumulation of polyubiquitinated/misfolded proteins (PMID:21487003, PMID:22884543). Genetic ablation in mice arrests pachytene spermatocytes in meiotic prophase I and triggers their apoptosis, establishing an essential role in spermatogenesis (PMID:21487003), a function conserved through the Drosophila ortholog Hsc70Cb, which human HSPA4 cDNA partially rescues. In the heart, HSPA4 loss causes accumulation of polyubiquitinated proteins and drives hypertrophy and fibrosis through gp130-STAT3, CaMKII, and calcineurin-NFAT signaling (PMID:22884543), and together with its redundant paralog HSPA4L it is required for embryonic lung maturation, with double-knockout mice showing pulmonary hypoplasia and accumulated ubiquitinated proteins (PMID:23980576). Beyond chaperone-associated proteostasis, HSPA4 is subject to regulation and moonlighting roles: SIRT1 deacetylates it at K305/K351/K605 to drive nuclear translocation that represses proinflammatory cytokine expression in glia (PMID:35158021), and cytoplasmic HSPA4 binds transferrin to limit iron uptake and attenuate ferroptosis in dopaminergic neurons (PMID:41068261). In cancer, membrane-displayed glycosylated HSPA4 binds ITGB5 and, when ligated by tumor-educated B-cell IgG, activates Src/NF-κB signaling to promote lymph-node metastasis (PMID:30643287), while intracellular HSPA4 stabilizes the m6A demethylase ALKBH5 to suppress CD58 and impair CD8+ T-cell cytotoxicity (PMID:38589927). HSPA4 also promotes clathrin-mediated viral endocytosis by activating PI3K-Akt to upregulate clathrin heavy chain and by increasing HSC70 ATPase activity (PMID:39599898).

1. 2002 Medium

   Whether HSPA4 contributes to stress-protective adaptation was unknown; this work showed it mediates a cytoprotective radioadaptive response.

   Evidence Hspa4 transgenic mice with low-dose pre-irradiation followed by high-dose challenge and cell-death assays in splenocytes

   PMID:12005543

   Open questions at the time

   • Mechanism linking HSPA4 levels to survival not defined
   • No molecular targets identified
   • Effect on intact tissue/organism survival not assessed
2. 2011 High

   The physiological requirement for HSPA4 as an HSP70 nucleotide exchange factor was unestablished; knockout revealed an essential role in completing meiotic prophase I during spermatogenesis.

   Evidence Hspa4 knockout mouse with histology, TUNEL, and spermatocyte transcript profiling

   PMID:21487003

   Open questions at the time

   • Specific client proteins protected during meiosis not identified
   • Whether NEF activity per se is the rescuing function not directly tested
   • Mechanism of pachytene-stage specificity unknown
3. 2011 Medium

   Whether HSPA4 could be co-opted to promote malignant behavior was unknown; an NBS1-HSF4b-HSPA4 transcriptional axis was shown to drive migration, invasion, and anchorage-independent growth.

   Evidence RT-PCR, Western blot, siRNA knockdown, migration/invasion and soft-agar assays in H1299 cells

   PMID:21208456

   Open questions at the time

   • Downstream effectors of HSPA4 in this context undefined
   • In vivo metastasis not tested
   • Direct vs. indirect transcriptional control by HSF4b not resolved
4. 2012 High

   The role of HSPA4 in maintaining proteostasis in a post-mitotic tissue was unknown; knockout established it is required for cardiac protein quality control and restrains hypertrophic signaling.

   Evidence Hspa4 knockout mice with pressure-overload model, polyubiquitin/hypertrophic-marker blots, echocardiography, and neonatal cardiomyocyte culture

   PMID:22884543

   Open questions at the time

   • Direct cardiac client proteins not identified
   • Causal order between aggregate accumulation and signaling activation unresolved
   • Whether NEF activity mediates the cardioprotection not directly shown
5. 2014 High

   Whether HSPA4 acts alone was unclear; double-knockout epistasis demonstrated functional redundancy with HSPA4L in embryonic lung maturation.

   Evidence Hspa4l/Hspa4 double-knockout mice with histology, surfactant-protein immunofluorescence, and ubiquitin/Bcl-2 blots

   PMID:23980576

   Open questions at the time

   • Tissue-specific contribution of each paralog not dissected
   • Pneumocyte client proteins unidentified
   • Mechanism of redundancy at the molecular level unknown
6. 2019 High

   An extracellular/moonlighting role was undescribed; membrane-glycosylated HSPA4 was shown to bind ITGB5 and transduce tumor-IgG signals into Src/NF-κB-driven lymph-node metastasis.

   Evidence Spontaneous metastasis mouse model, B-cell depletion, IgG transfer, reciprocal HSPA4-ITGB5 binding assays, and human serum ELISA

   PMID:30643287

   Open questions at the time

   • How chaperone HSPA4 reaches and is glycosylated at the plasma membrane unknown
   • Structural basis of HSPA4-ITGB5 interaction not resolved
   • Relationship to its intracellular NEF function unaddressed
7. 2022 High

   Post-translational control of HSPA4 localization and immune function was unknown; SIRT1-mediated deacetylation at K305/K351/K605 was shown to drive nuclear translocation and anti-inflammatory activity.

   Evidence Co-IP, K-to-R site-directed mutagenesis, subcellular fractionation, and SIRT1 transgenic mice in an MPTP PD model

   PMID:35158021

   Open questions at the time

   • Nuclear targets/mechanism of cytokine repression undefined
   • Which residue dominates the localization switch unclear
   • Connection to chaperone activity in the nucleus unknown
8. 2024 Medium

   Whether HSPA4 modulates anti-tumor immunity was unknown; it was shown to stabilize ALKBH5 and suppress CD58 via m6A regulation, enabling immune evasion in gastric cancer.

   Evidence Co-IP, meRIP, CD8+ T-cell co-culture cytotoxicity assays, and HSPA4 gain/loss of function

   PMID:38589927

   Open questions at the time

   • Whether ALKBH5 stabilization reflects classic chaperone activity unclear
   • Direct vs. indirect CD58 regulation not fully resolved
   • In vivo immune-evasion contribution not quantified
9. 2024 Medium

   A role in pathogen entry was untested; HSPA4 was shown to promote clathrin-mediated endocytosis and viral entry via PI3K-Akt/clathrin upregulation and increased HSC70 ATPase activity.

   Evidence HSPA4 knockdown/overexpression, viral titer/copy assays, IFA, PI3K-Akt inhibition, and ATPase activity assays in BRSV infection

   PMID:39599898

   Open questions at the time

   • Direct molecular link from HSPA4 to PI3K-Akt activation undefined
   • Whether HSPA4 acts as NEF for HSC70 in this setting not shown
   • Generality across other viruses unknown
10. 2024 Medium

    Upstream regulation of HSPA4 in stem-cell differentiation was unknown; it was placed as the functional effector of a LINC01089/miR-1287-5p axis controlling osteogenesis.

    Evidence Dual-luciferase reporter, RIP, RT-qPCR/Western blot, and ALP/alizarin-red osteogenesis assays with knockdown

    PMID:39679709

    Open questions at the time

    • Mechanism by which HSPA4 promotes osteogenic differentiation undefined
    • In vivo bone phenotype not assessed
    • Whether chaperone function is involved unknown
11. 2024 Medium

    The evolutionary conservation of HSPA4's spermatogenic function was unconfirmed; human HSPA4 partially rescued germ-cell loss in Drosophila Hsc70Cb mutants.

    Evidence Nanos-Gal4 RNAi knockdown and human HSPA4 cDNA cross-species rescue in Drosophila testis (preprint)

    Open questions at the time

    • Preprint not yet peer-reviewed
    • Rescue is only partial; full functional equivalence not established
    • Conserved client proteins not identified
12. 2025 Medium

    Whether HSPA4 influences metal homeostasis and cell death was unknown; cytoplasmic HSPA4 was shown to bind transferrin, restrict iron uptake, and attenuate ferroptosis in dopaminergic neurons.

    Evidence Co-IP, HSPA4 gain/loss of function in SH-SY5Y and primary neurons, MPTP PD model, ferroptosis assays, and behavioral testing

    PMID:41068261

    Open questions at the time

    • Structural basis of HSPA4-transferrin interaction unresolved
    • Whether the effect depends on chaperone/NEF activity unknown
    • Reciprocal validation of the interaction limited

• How HSPA4's core HSP70 nucleotide-exchange activity mechanistically connects to its diverse moonlighting roles (membrane antigen, transferrin binding, ALKBH5 stabilization, nuclear cytokine repression) and which specific client proteins it protects in each tissue remain unresolved.
• No tissue-specific HSPA4 client/substrate catalog
• No structural model linking NEF activity to non-canonical interactions
• Mechanism of plasma-membrane and nuclear targeting undefined